Geographical inequalities in care in the UK National Health Service (NHS) may relate to the physical distance between patients and NHS facilities. In Scotland, official policy in the government's response to the Kerr report, supports the greater provision of acute services in the community.[@b1] [@b2] Geographical inequality for patients with myocardial infarction (MI) may be related to time to thrombolysis as it is established that early thrombolysis and cardiopulmonary resuscitation improve the mortality outcome.[@b3] [@b4] Geographical inequality could also be explained by more stoical behaviour of subjects in a rural setting or other factors. We have done a large population-based study to investigate the effect of distance between home and acute hospital on mortality outcome of patients experiencing an incident MI.

METHODS {#s2}
=======

The study was carried out in Tayside, Scotland, using the Medicines Monitoring Unit's record-linkage database. The database covers a population of approximately 400 000 within a geographical area of approximately 4600 square miles. The data collection methods for this database have previously been described.[@b5] In brief, it contains several datasets including all dispensed community prescriptions, hospital discharge data, biochemistry results and other datasets that are linked by a unique patient identifier, the community health number. Diagnoses have been validated by inspection of the general practitioner (GP) records.[@b6] These data are anonymised for the purposes of research. The project was approved by the Tayside Caldicott Guardians who are appointed by the government to protect the confidentiality of medical records and the Tayside committee on research medical ethics.

Patient population {#s2a}
------------------

The study population included subjects who were resident in Tayside and registered with a GP in January 1994 and remained in Tayside until December 2003 or died during the study period---a fixed population (n = 347 131). Study subjects were patients experiencing an incident MI who had not previously been hospitalised with a diagnosis of acute MI between January 1994 and December 2003.

### Prehospital coronary mortality {#s2a1}

We studied patients who died out-of-hospital with a primary certified cause of death (data from the General Register Office for Scotland) of MI (ICD-9 code 410 and ICD-10 code I21).

### Patients hospitalised with MI and follow-up mortality {#s2a2}

Patients admitted to Tayside hospitals with their first MI were identified from the Tayside hospital discharge data using the primary diagnosis ICD-9 code of 410 and ICD-10 code I21. We tracked the all-cause mortality of patients during their hospital stay and following discharge from hospital.

Distance between home and hospital of admission {#s2b}
-----------------------------------------------

Distance between home and hospital of admission was calculated based on the grid reference of the postcode of the patient's address and the grid reference of the address of the admitting hospital. For patients who died outside hospital the grid reference of their nearest acute hospital was used to calculate the distance between home and the closest possible hospital of admission. The thrombolytic treatment strategy for Tayside during the study period was in-hospital initiation of treatment. About half of the patients lived within 5 miles (8 km) from these hospitals and 98.5% patients lived within 25 miles. The distance between home and hospital was thus categorised into tertiles: (1) distance \<3 miles; (2) distance between 3--9 miles; (3) distance \>9 miles. We obtained a rurality code from patient postcodes (that is, urban and rural classification of postcodes for Scotland, a code of 1 means large urban area with settlement of over 125 000 people and a code of 8 means very remote rural area with settlement of fewer than 3000 people with a drive time of over 60 minutes to a settlement of 10 000 or more).[@b7] We also calculated the travel time by car along the road network, the car speed being based on the speed limit for the different types of road.

Thrombolysis data {#s2c}
-----------------

Three major hospitals (Ninewells Hospital, Perth Royal Infirmary and Stracathro Hospital) in Tayside provided acute services. All these hospitals had coronary care units and accredited cardiologists working in them. However, catheter laboratory facilities were available only at Ninewells Hospital. In-hospital thrombolysis data were available for Ninewells Hospital between December 2001 and December 2004 (n = 366). We used these data in a subgroup analysis of patients to access the impact of thrombolysis on outcome.

Postmortem examination for community MI death {#s2d}
---------------------------------------------

Data were obtained from the General Register Office for those patients who had been certified as an MI death in the community and who also had a subsequent postmortem examination. These subjects were more likely to be those in whom there was some diagnostic uncertainty and many of these post mortems were carried out for medicolegal reasons.

Study outcome {#s2e}
-------------

The outcome was the individual components: prehospital MI mortality, in-hospital all-cause mortality and follow-up all-cause mortality until 31 December 2003.

Statistical analysis {#s2f}
--------------------

Patients' characteristics were summarised as mean (SD) for continuous variables and number of subjects (%) for categorical variables. The χ[@b2] and t tests were performed to determine significant differences between dead and alive patients. The Scottish 2000 standard population was used to calculate the age-standardised mortality rates. A logistic regression model was used to estimate the effects of distance between home and hospital of admission for both prehospital mortality and in-hospital mortality. Survival analysis was used to estimate the effects of distance between home and hospital of admission for post-hospital mortality since patients had different follow-up times. The results were adjusted for demographic information including age, gender, Carstairs deprivation score (derived from the patients' postcode and census data comprising social class, overcrowding, male unemployment and non-car ownership[@b8]), other covariates including day of week of admission,[@b9] diabetes mellitus, and cardiovascular drug use (lipid-lowering drugs, antiplatelet drugs, β-blockers, angiotensin-converting enzyme (ACE) inhibitors, diuretics, nitrates, α-blockers, calcium blockers), interactions between distance and social deprivation or gender and estimated travel time and rurality. All statistical analyses were carried out using SAS version 8.2 (SAS institute, Cary, NC, USA).

RESULTS {#s3}
=======

This study included 10 541 patients ([fig 1](#hrt-94-09-1141-f01){ref-type="fig"}). [Table 1](#hrt-94-09-1141-t01){ref-type="table"} shows the characteristics of the patients. The estimated median travel times by car from home and admitted hospital were 5.9 minutes (interquartile range (IQR) 3.3--8.9), 15.2 minutes (IQR 11.4--18.2) and 37.1 minutes (IQR 30.2--41.1) for the short, medium and long-distance groups, respectively.

![Flow chart of patients in the study.](HRT-94-09-1141-f01){#hrt-94-09-1141-f01}

###### Characteristics of patients following myocardial infarction, Tayside

                                                   Prehospital   In-hospital   Post-hospital                                                
  ----------------------------------------------- ------------- ------------- --------------- ------ ------ ---------- ------ ------ ------ ----------
  Distance (miles)†                                                                                                                         
      \<3                                             1287          31.7            407        41.6   1753   33.0\*\*   678    36.5   1075   31.1\*\*
      3--9                                            1346          33.2            304        31.0   1801     33.9     607    32.7   1194     34.6
      \>8                                             1423          35.1            268        27.4   1756     33.1     572    30.8   1184     34.3
  Sex                                                                                                                                       
      Male                                            2029          49.1            443        43.9   3270   60.6\*\*   1017   53.3   2253   64.5\*\*
      Female                                          2104          50.9            567        56.1   2128     39.4     890    46.7   1238     35.6
  Age (mean, SD)                                      77.2          10.9           78.5        9.6    67.5   12.6\*\*   74.6   10.2   63.7   12.1\*\*
  Deprivation category†                                                                                                                     
      1, least deprived                                175           4.4            47         4.8    313      5.9      100    5.4    213      6.1
      2                                                833          20.9            172        17.4   980      18.4     325    17.6   655      18.8
      3                                               1187          29.8            312        31.6   1508     28.3     502    27.3   1006     28.8
      4                                                424          10.7            122        12.3   561      10.5     216    11.7   345      9.9
      5                                                487          12.2            111        11.2   648      12.2     221    12.0   427      12.2
      6+, most deprived                                876          23.0            225        22.8   1320     24.8     478    26.0   742      24.1
  Travel time (mean, SD)                               --            --            17.3        15.3   19.3   14.9\*\*   20.4   15.7   18.7   15.4\*\*
  Urban-rural code‡                                                                                                                         
      1                                               1603          40.5            385        38.6   2356   44.0\*\*   813    43.5   1543     44.2
      2                                               1003          25.4            289        29.0   1410     26.3     527    28.2   883      25.3
      3, 6                                            1181          29.9            280        18.0   1431     26.7     467    25.0   964      27.6
      7, 8                                             167           4.2            44         4.4    163      3.0       62    3.3    101      2.9
  Previous hospitalisation                                                                                                                  
      Angina                                           445          10.8            121        12.0   691      12.8     295    15.5   396    11.3\*\*
      Heart failure                                    845          20.5            277        27.4   1402   26.0\*\*   821    43.1   581    16.6\*\*
      Stroke                                           433          10.5            111        11.0   271    5.0\*\*    173    9.1     98    2.8\*\*
      Hypertension                                     432          10.5            131        13.0   645     12.0\*    233    12.2   412    11.8\*\*
      PVD                                              462          11.2            128        12.7   423    7.8\*\*    232    12.2   191    5.5\*\*
      Diabetes                                         567          13.7            146        14.5   715      13.2     327    17.2   388    11.1\*\*
  Cardiovascular drug use in the previous year‡                                                                                             
      Lipid-lowering drug                              325           7.9            97         9.6    667     12.4\*    554    29.1   2660   76.2\*\*
      Antiplatelets                                   1569          38.0            386        38.2   1556   28.8\*\*   1205   63.2   2907   83.3\*\*
      β-blockers                                      1148          27.8            302        29.9   1684     31.2     539    28.3   2264   64.9\*\*
      ACE inhibitors                                   868          21.0            188        18.6   787    14.6\*\*   765    40.1   2054   58.8\*\*
      Diuretics                                       2570          62.2            628        62.2   2110   39.1\*\*   1052   55.2   1388   39.8\*\*
      α-blockers                                       198           4.8            56         5.5    257    4.8\*\*     54    2.8    123      3.5
      Nitrates                                        1438          34.8            374        37.0   1627   30.1\*\*   1047   54.9   2435   69.8\*\*
      Ca-blockers                                     1370          33.2            370        36.6   1694     31.4     518    27.2   1177   33.7\*\*

Data are numbers and percentages unless otherwise stated.

\*Comparison of dead and alive patients, p\<0.05; \*\*p\<0.01. †Excluding missing data. ‡Drug uses during the follow-up for post-hospital cohort.

ACE, angiotensin-converting enzyme; PVD, peripheral vascular disease.

Prehospital mortality {#s3a}
---------------------

In all, 4133 patients with MI as the primary certified cause of death died without being hospitalised or before they reached a hospital ([table 1](#hrt-94-09-1141-t01){ref-type="table"}). The age-adjusted death rate was 8.4% (8.0% for men and 9.3% for women); 50.9% of patients were women and 35.1% of patients lived \>9 miles from the hospital. Compared with patients living \<3 miles from hospitals those living \>3 miles from hospital had higher MI mortality (adjusted OR 1.46, 95% CI 1.09 to 1.95 for 3--9 miles and 2.05, 1.00 to 4.21 for \>9 miles).

### Diagnostic accuracy of community MI death {#s3a1}

About 10% of patients certified as a community MI death had postmortem examinations. The postmortem results showed that MI was the cause of death in over 95% of these subjects during the study period.

In-hospital mortality {#s3b}
---------------------

A total of 6408 patients (57.9% male) survived to be hospitalised with incident acute MI during the study period and 1010 of these (15.8%) died in hospital (that is, case fatality). The median duration of hospitalisation was 2 days. Except for β-blocker use patients who died in hospital had received more cardiovascular drug prescriptions in the previous year than patients who survived. There were significant differences in gender, age and social deprivation between patients who survived and those who died. Women and older patients had higher risk of mortality than men and young patients. The age-adjusted death rate was 11.6% (12.3% for men and 10.8% for women). There were more women living closer to hospital than men. The percentages of women in each distance category were 36.2%, 33.1% and 30.6% for \<3 miles, 3--9 miles and \>9 miles distance groups, respectively.

There was no increased risk of death in hospital with increasing distance between home and hospital of admission ([table 2](#hrt-94-09-1141-t02){ref-type="table"}).

###### Adjusted odds ratios (OR) or hazard ratios (HR) for mortality in patients with MI

                                 Prehospital   In-hospital   Post-hospital
  ----------------------------- ------------- ------------- ---------------
  Distance (miles), tertile\*                               
      \<3                         1287/3447     407/2160       678/1753
      3--9                        1346/3451     304/2105       607/1801
      \>9                         1423/3447     268/2024       572/1756

\*Other covariates included day of week of admission, previous cardiovascular disease, diabetes mellitus, cardiovascular drug use and interactions between distance and deprivation/sex. Analysis was done by excluding missing data.

Follow-up mortality {#s3c}
-------------------

In all, 5398 patients (3260 men, 2128 women) were discharged from hospital and were followed up for a median of 3.2 years (IQR 1.1--6.2). Of these, 1907 patients (35.3%, 1017 men and 890 women) died during the follow-up period. The age-adjusted death rate was 8.6% (8.4% for men and 9.4% for women). There was a significantly increased use of statins and other cardiovascular drugs following hospitalisation compared with previous drug use ([table 1](#hrt-94-09-1141-t01){ref-type="table"}). Patients who survived during follow-up had higher prescribing rates for cardiovascular drugs than patients who died (as we have shown before).[@b10] A total of 3214 patients (59.5%) were taking lipid-lowering drug treatment and, of these, 3194 (99.4%) were taking statin treatment.

After adjustment for other risk factors, patients who lived \>9 miles from the hospital had an increased risk of mortality during the follow-up period when compared to patients who lived \<3 miles from the hospital (adjusted HR 1.90, 95% CI 1.19 to 3.02) ([table 2](#hrt-94-09-1141-t02){ref-type="table"}). A non-significant increased mortality was seen for those who lived 3-9 miles from the hospital (adjusted HR 1.27, 95% CI 0.96 to 1.68).

### Effect of cardiovascular drugs {#s3c1}

Compared with non-users, users of lipid-lowering drugs (adjusted HR 0.47, 95% CI 0.42 to 0.53), antiplatelet drugs (adjusted HR 0.40, 95% CI 0.35 to 0.45), β-blockers (adjusted HR 0.55, 95% CI 0.49 to 0.62) and ACE inhibitors (adjusted HR 0.84, 95% CI 0.75 to 0.93) during the follow-up had a significantly lower risk of mortality.

### Thrombolysis {#s3c2}

A total of 209 out of 5398 (3.8%) patients had thrombylosis data for the follow-up analysis. This subgroup analysis suggested that early thrombolysis reduced mortality (adjusted HR 0.63, 95% CI 0.37 to 1.07), However, early thrombolysis did not change the direction of the impact of distance (adjusted HR 1.86, 95% CI 0.49 to 7.02 for patients who lived 3--9 miles from the hospital, adjusted HR 1.43, 95% CI 0.18 to 11.39 for patients who lived \>9 miles from the hospital when compared with patients who lived \<3 miles from the hospital).

DISCUSSION {#s4}
==========

Previous studies have shown a relation between the treatment delay and mortality outcome in MI patients.[@b11]^--^[@b14] However, few studies have investigated the impact of geographical location and none has been representative of a complete population.[@b15] Our data suggest that the distance between home and hospital of admission predicts mortality in subjects experiencing first acute MI both in the community (prehospital) and following discharge from hospital after adjustment for urban-rural code or travel time and other covariates. There was no difference if these results were adjusted only for age, sex and other covariates, suggesting that urban-rural code and travel time are the significant confounders. Other areas that could cause a delay between the onset of symptoms and treatment are the delay by patients in calling for help and the delay between calling for help and the attendance of a doctor. We could not measure these but they could be investigated.[@b16] However, we used a measure of rurality as a possible surrogate measure of patient behaviour in the different geographical settings.

The median travel time was 37 minutes for patients who lived \>9 miles from an acute hospital. This time does not include time taken for the ambulance to reach the patient. In addition, these times take no account of adverse traffic or weather conditions. We think that it is unlikely that this group of patients could have met the national target for thrombolysis within 60 minutes of a call for help.

Geographical inequality and early thrombolysis {#s4a}
----------------------------------------------

Our data support the concept that there is geographical inequality of care in patients who have had an acute incident MI. An excess in coronary heart disease (CHD) death rates in young patients was reported outside the state capital cities in Australia.[@b17] The risk factors between the populations and inadequacies in the level of medical care provided were the two main reasons that have been used to explain this excess CHD death. A recent US study showed that a mile increase in distance leads to a nearly 6.5% increase in the number of deaths from a heart attack.[@b18] However in Scotland, the National Health Service is tax funded, free at the point of consumption and covers the entire population. There should thus be no socioeconomic eligibility distinctions in the level of health care given to an individual, being based on need alone. One hypothesis is that the time delay related to distance plays an important part in the prognosis of MI patients. A study from our own region demonstrated that an early thombolysis treatment strategy was achievable and improved outcome.[@b19] However when we adjusted for travel time this did not explain the association between distance from acute facilities and mortality.

A US Veteran Affairs (VA) study investigated the effect of distance between home and hospital of admission on mortality in male post-MI patients.[@b15] They compared the mortality outcome between patients (64%) who lived more than 20 miles from any VA health source and patients (36%) who lived within 20 miles. They found a positive relation between distance and follow-up mortality. However they studied only men and their results may not be generalisable to other healthcare systems. Our study indicates that the distance from home to hospital of admission is an important factor that predicts survival following acute MI.

Study limitations and strengths {#s4b}
-------------------------------

There are some limitations in our study. First, we did not have information on smoking, obesity, severity of MI, invasive management after discharge, the treating specialist at the admitting hospital and other unmeasured risk factors, all of which are likely to be important in patients with heart disease. However, we did use the Carstairs socioeconomic deprivation score as a surrogate measure for at least some of these factors.[@b20] [@b21] Also, our previous sensitivity analysis on unmeasured risk factors showed that at least some of these unknown risk factors were unlikely to make a big impact on cardiovascular outcome.[@b22] Second, the distance we used in this study was based on home and hospital addresses. We did not know the exact location of the patients when they had a heart attack. However, given the average age of 72, we would expect that the majority of patients would have had their MI at or near their home. Third, we did not have information on the time of onset of MI symptoms. Fourth, we used linear distance and estimated travel time in the study. However, distance along the road network may be different and there may have been differences in traffic conditions at different times of day.

We observed independent risk reductions in mortality during the follow-up period for lipid-lowering drugs, antiplatelet drugs and β-blockers consistent with the finding from clinical trials and other observational studies.[@b23]^--^[@b28] However we may have underestimated the benefits of cardiovascular drugs because we assumed all patients complied with their drug treatment when in reality this is rarely the case.[@b28] Finally, the diagnostic accuracy of MI death before hospitalisation is open to question. The data retrieved from the General Register Office revealed that in those subjects who had postmortem examinations performed, the diagnosis of MI was almost always confirmed. Presumably those subjects who underwent post mortems were those in whom the diagnosis was in question and was more likely to be incorrect. Thus these postmortem data are reassuring and suggest that prehospital MI death data were reasonably accurate.

The strength of our study is the population-based cohort design, with complete follow-up over the study period. This approach allows a "real-world" population to be studied, representing all socioeconomic groups and within a universal healthcare coverage scheme.[@b29] The results inform us that there may be geographical inequality in healthcare delivery, the cause of which is currently difficult to explain. This relation may influence healthcare policy on the provision of prehospital care such as thrombolysis for MI, the enhanced provision of paramedics and the greater delivery of ambulance services to remote communities. It is in line with the recent Kerr report in Scotland calling for services to be delivered closer to patients wherever possible,[@b30] and studies demonstrating that managed clinical networks can achieve this goal.[@b31]

In conclusion, our data suggested that distance from home to hospital may predict mortality outcome in subjects experiencing an acute MI. These data provide support for policies that locate services for acute MI closer to where patients live.
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